behind a significant rise in the early detection of this pernicious cancer.
To achieve our purpose, we are
with scientific and clinical partners.
is a blood-based tool that has been developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer, and is now ready for validation studies. We have a CLIA certified laboratory in Thousand Oaks, California. Our objective is to have our test FDA approved.